N01269 115 is a clinical research site located in Birmingham, Alabama, United States 35233.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
N01269 115 has participated in 1 clinical trials.
Therapeutic areas: Childhood Absence Epilepsy, Juvenile Absence Epilepsy.
Sponsors: UCB Biopharma SRL.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
N01269 115 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
N01269 115 has 1 clinical trials on record. Their work covers Childhood Absence Epilepsy, Juvenile Absence Epilepsy.
N01269 115 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.